CURE Pharmaceutical Announces Closing of $1 Million Bridge Financing and Prepares to Uplist to NASDAQ

OXNARD, Calif., March 23, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it secured a $1 million bridge financing from accredited investors for working capital and the potential uplisting to NASDAQ. Alexander Capital, LP acted as the sole placement agent for the transaction. “This capital raise…